Early diabetes drug test seeks safety and absorption clues
NCT ID NCT07304687
Summary
This early-stage study aimed to understand how the body processes and tolerates a new combination pill for type 2 diabetes, called CKD-383. Researchers compared it to taking its three separate drug components together. The study involved 31 healthy adult volunteers to measure drug levels in the blood and check for safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
H Plus Yangji Hospital
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.